In 2021, JCMT journal made considerable progress and breakthroughs. On the occasion of the coming of the new year, the Editorial Office would like to express our sincere gratitude to all the authors, readers, reviewers, and Editorial Board members who have always supported JCMT. The Editorial Office hereby reviews the overall development of JCMT in 2021 as follows:
1. Editorial Board
As of December 31, 2021, the Editorial Board of JCMT journal consists of 134 members from 16 countries. These countries include the United States(50), Italy(25), Japan(3), Germany(8), China(8), France(4), the Netherlands(2), the United Kingdom(5), Portugal(3), Belgium(3), Spain (2), Australia(6), India(8), Austria(1), Singapore(1), Greece(1), Switzerland(2), Slovenia(1), Israel(1), South Korea(1), Russia(1).
The authors of JCMT come from 29 countries around the world. More than 75% of the authors are from the United States (43%), Italy (10%), Japan (9%), the United Kingdom(7%), Germany (4%), Portugal(3%), France (3%), the Netherlands(3%), Spain(3%), Brazil(3%).
As of December 31, 2021, the readership of JCMT journal is distributed globally, including the United States (35%), the United Kingdom(8%)， India (8%), China (4%), Canada (3%)，Italy (3%), Australia (3%), South Korea(2%), Japan(2%), Germany (2%) and other 205 countries.
4. Published Papers
In 2021,JCMT received 220 submissions and published 70 articles after strict and standard peer-review, including 13 original articles, 52 reviews, 4 editorials, and 1 perspective.
Total Views in 2021: 325,754
Total Downloads in 2021: 66, 737
On August 16, under the leadership of Prof. Hendrik Paul Van Poppel from European Association of Urology (EAU), Dept Urology, University Hospital KU Leuven, Belgium, online webinar “Metastatic Renal Cell Carcinoma” was successfully held.
6. Indexing progress
On the premise of insisting on high-quality publishing, JCMT has also made good progress in database indexing. In March 2021, JCMT was indexed by American Chemical Abstracts Service(CAS). In May 2021, JCMT was indexed by Scopus database.
The Editorial Office of JCMT is committed to guaranteeing accurate and fair evaluation and prompting the published papers to create a solid and successful scientific journal. JCMT will continue to adhere to high-quality publishing and fast-response services and bring more wonderful articles and webinars to the cancer treatment field.
Thanks again to all the experts who have contributed to JCMT in publications, reviews, and webinars. We look forward to the editorial department and the Editorial Board team to jointly build a bountiful 2022.
Respectfully Submitted by the Editorial Office of Journal of Cancer Metastasis and Treatment